HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Am. J. Physiol. Heart Circ. Physiol. (3)
- Proc. Natl. Acad. Sci. U.S.A. (1)
- Stem Cells Transl Med (1)
- Others (13)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Robinson SP et al. | Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. | 2003 | Br. J. Cancer | pmid:12771928 |
| Wani KM et al. | Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma. | 2003 | Br. J. Cancer | pmid:12771926 |
| Yu J et al. | Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. | 2003 | Br. J. Cancer | pmid:12771922 |
| Mizunuma H et al. | The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity. | 2003 | Br. J. Cancer | pmid:12771919 |
| Ribatti D et al. | Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma. | 2006 | Br. J. Cancer | pmid:16721359 |
| Nieto Y et al. | Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. | 2007 | Br. J. Cancer | pmid:17609662 |
| Zaman MS et al. | The functional significance of microRNA-145 in prostate cancer. | 2010 | Br. J. Cancer | pmid:20588276 |
| Overman MJ et al. | Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. | 2010 | Br. J. Cancer | pmid:19935793 |
| Zlobec I et al. | Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. | 2010 | Br. J. Cancer | pmid:19935791 |
| Dubois L et al. | Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry. | 2004 | Br. J. Cancer | pmid:15520822 |
| Aoki S et al. | Prognostic significance of dysadherin expression in advanced colorectal carcinoma. | 2003 | Br. J. Cancer | pmid:12618882 |
| Colpaert CG et al. | Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. | 2003 | Br. J. Cancer | pmid:12618881 |
| Koukourakis MI et al. | Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference? | 2003 | Br. J. Cancer | pmid:12618880 |
| Tani N et al. | Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. | 2003 | Br. J. Cancer | pmid:12610521 |
| Kato K et al. | Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. | 2008 | Br. J. Cancer | pmid:18665171 |
| Stumpf M et al. | Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. | 2009 | Br. J. Cancer | pmid:19861998 |
| Sardari Nia P et al. | Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. | 2004 | Br. J. Cancer | pmid:15328525 |
| Le Page C et al. | Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. | 2006 | Br. J. Cancer | pmid:16721361 |
| Nam SY et al. | A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis. | 2011 | Br. J. Cancer | pmid:21119667 |
| Lamont FR et al. | Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo. | 2011 | Br. J. Cancer | pmid:21119661 |
| Salgado R et al. | Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer. | 2002 | Br. J. Cancer | pmid:12454774 |
| Offersen BV et al. | Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. | 2002 | Br. J. Cancer | pmid:12454772 |
| Batistatou A et al. | In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. | 2007 | Br. J. Cancer | pmid:17437014 |
| McCall P et al. | Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients. | 2008 | Br. J. Cancer | pmid:18349820 |
| Querzoli P et al. | An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. | 2010 | Br. J. Cancer | pmid:21063415 |
| Fujimori K et al. | Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. | 2005 | Br. J. Cancer | pmid:15655559 |
| van Hattum AH et al. | Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity. | 2002 | Br. J. Cancer | pmid:12237778 |
| Watters AD et al. | Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. | 2002 | Br. J. Cancer | pmid:12237776 |
| Mukherjee P et al. | Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. | 2002 | Br. J. Cancer | pmid:12085212 |
| Hoffman BR et al. | Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. | 2002 | Br. J. Cancer | pmid:12232761 |
| Løvig T et al. | Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. | 2002 | Br. J. Cancer | pmid:12232760 |
| Hoskin PJ et al. | GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. | 2003 | Br. J. Cancer | pmid:14520462 |
| Vizoso FJ et al. | Study of matrix metalloproteinases and their inhibitors in breast cancer. | 2007 | Br. J. Cancer | pmid:17342087 |
| West NP et al. | The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. | 2010 | Br. J. Cancer | pmid:20407439 |
| Belien JA et al. | Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. | 2009 | Br. J. Cancer | pmid:19738619 |
| Liggins AP et al. | A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein. | 2004 | Br. J. Cancer | pmid:15162151 |
| Lee YC et al. | Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. | 2004 | Br. J. Cancer | pmid:15150628 |
| Wang YF et al. | Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. | 2004 | Br. J. Cancer | pmid:15150613 |
| Renaudin K et al. | Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling. | 2004 | Br. J. Cancer | pmid:15150612 |
| Staal FJ et al. | A novel germline mutation of PTEN associated with brain tumours of multiple lineages. | 2002 | Br. J. Cancer | pmid:12085208 |
| Ito Y et al. | Expression of cdc25A and cdc25B proteins in thyroid neoplasms. | 2002 | Br. J. Cancer | pmid:12085185 |
| Kummar S et al. | Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. | 2002 | Br. J. Cancer | pmid:12085180 |
| Hu L et al. | Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. | 2010 | Br. J. Cancer | pmid:20354527 |
| Grelier G et al. | Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. | 2009 | Br. J. Cancer | pmid:19672267 |
| Berta GN et al. | Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas. | 2005 | Br. J. Cancer | pmid:16265350 |
| Boneberg EM et al. | Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. | 2009 | Br. J. Cancer | pmid:19672262 |
| Zou M et al. | S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. | 2005 | Br. J. Cancer | pmid:16265347 |
| Mollevà DG et al. | PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. | 2008 | Br. J. Cancer | pmid:19002188 |
| Buffart TE et al. | MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. | 2008 | Br. J. Cancer | pmid:19002170 |
| Knight JF et al. | TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. | 2008 | Br. J. Cancer | pmid:19002168 |
| Miyoshi A et al. | Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. | 2004 | Br. J. Cancer | pmid:15026811 |
| Dales JP et al. | Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). | 2004 | Br. J. Cancer | pmid:15026804 |
| Hague S et al. | Tamoxifen induction of angiogenic factor expression in endometrium. | 2002 | Br. J. Cancer | pmid:11875740 |
| Cascinu S et al. | An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. | 2002 | Br. J. Cancer | pmid:11875737 |
| Duda DG et al. | Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis. | 2002 | Br. J. Cancer | pmid:11875720 |
| Wang JJ et al. | Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells. | 2003 | Br. J. Cancer | pmid:14612915 |
| Adib TR et al. | Predicting biomarkers for ovarian cancer using gene-expression microarrays. | 2004 | Br. J. Cancer | pmid:14760385 |
| Kawaguchi K et al. | Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype. | 2004 | Br. J. Cancer | pmid:14760383 |
| Choudhury A et al. | MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. | 2004 | Br. J. Cancer | pmid:14760381 |
| Al-Saad S et al. | The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. | 2008 | Br. J. Cancer | pmid:18854838 |
| McCall P et al. | Is PTEN loss associated with clinical outcome measures in human prostate cancer? | 2008 | Br. J. Cancer | pmid:18854827 |
| Brunstein F et al. | Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery. | 2006 | Br. J. Cancer | pmid:17106443 |
| Reddy A et al. | Analysis of CHK2 in vulval neoplasia. | 2002 | Br. J. Cancer | pmid:11875739 |
| Cheng HL et al. | Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder. | 2005 | Br. J. Cancer | pmid:15870710 |
| Duncan R et al. | Characterisation and protein expression profiling of annexins in colorectal cancer. | 2008 | Br. J. Cancer | pmid:18071363 |
| Loussouarn D et al. | Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. | 2009 | Br. J. Cancer | pmid:19513072 |
| Charalambous MP et al. | Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. | 2009 | Br. J. Cancer | pmid:19513071 |
| Atkin GK et al. | The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. | 2006 | Br. J. Cancer | pmid:17016487 |
| Matsubara J et al. | Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. | 2008 | Br. J. Cancer | pmid:18231104 |
| Dietze A et al. | Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. | 2005 | Br. J. Cancer | pmid:15886704 |
| Shimada K et al. | Aberrant expression of RAB1A in human tongue cancer. | 2005 | Br. J. Cancer | pmid:15870709 |
| Latif Z et al. | HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. | 2003 | Br. J. Cancer | pmid:14520464 |
| Talvensaari-Mattila A et al. | Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. | 2003 | Br. J. Cancer | pmid:14520459 |
| Kallio JP et al. | Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. | 2003 | Br. J. Cancer | pmid:14520458 |
| Hata K et al. | Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. | 2003 | Br. J. Cancer | pmid:14520452 |
| Mahalingam D et al. | Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. | 2010 | Br. J. Cancer | pmid:20087343 |
| Shannon AM et al. | Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. | 2005 | Br. J. Cancer | pmid:15999100 |
| Eves P et al. | Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. | 2003 | Br. J. Cancer | pmid:14612916 |
| Oosterhoff D et al. | Secreted and tumour targeted human carboxylesterase for activation of irinotecan. | 2002 | Br. J. Cancer | pmid:12237777 |
| Youssef MM et al. | EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer. | 2006 | Br. J. Cancer | pmid:16929248 |
| Tsuji S et al. | Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. | 2010 | Br. J. Cancer | pmid:20628387 |
| Maruyama T et al. | Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma. | 2010 | Br. J. Cancer | pmid:20628381 |
| Polterauer S et al. | The impact of lymph node density on survival of cervical cancer patients. | 2010 | Br. J. Cancer | pmid:20628380 |
| Saeb-Parsy K et al. | MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3. | 2008 | Br. J. Cancer | pmid:18665176 |
| Caldwell GM et al. | Wnt signalling in adenomas of familial adenomatous polyposis patients. | 2010 | Br. J. Cancer | pmid:20628379 |
| Tanaka N et al. | Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:12888830 |
| Sonoda K et al. | Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. | 2003 | Br. J. Cancer | pmid:12888828 |
| Raccurt M et al. | Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. | 2003 | Br. J. Cancer | pmid:12888825 |
| Yoshino H et al. | The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. | 2011 | Br. J. Cancer | pmid:21304530 |
| Marques AR et al. | Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours. | 2004 | Br. J. Cancer | pmid:15238980 |
| Schimanski CC et al. | Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. | 2006 | Br. J. Cancer | pmid:16819541 |
| Van Laere SJ et al. | NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. | 2007 | Br. J. Cancer | pmid:17700572 |
| Yoshimoto M et al. | FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. | 2007 | Br. J. Cancer | pmid:17700571 |
| Arrieta O et al. | Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. | 2008 | Br. J. Cancer | pmid:18594540 |
| Koivunen JP et al. | Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. | 2008 | Br. J. Cancer | pmid:18594528 |
| Hart CA et al. | Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. | 2005 | Br. J. Cancer | pmid:15668715 |
| Attard G et al. | Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. | 2008 | Br. J. Cancer | pmid:18594527 |
| Okumura H et al. | The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma. | 2005 | Br. J. Cancer | pmid:15655547 |
| Cao P et al. | Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts. | 2009 | Br. J. Cancer | pmid:19319133 |
| Kuroda M et al. | The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target. | 2005 | Br. J. Cancer | pmid:15655544 |